Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The carotid artery disease treatment market is a crucial component of healthcare, focusing on addressing blockages or narrowing in the carotid arteries, which can lead to serious complications such as strokes and transient ischemic attacks (TIAs). Carotid artery disease occurs when the arteries in the neck that supply blood to the brain become narrowed or blocked by a buildup of plaque, a condition known as carotid artery stenosis. This market segment encompasses a range of treatment modalities aimed at reducing the risk of stroke and improving blood flow to the brain.
One of the primary treatment options for carotid artery disease is lifestyle modifications and risk factor management. Patients are often advised to adopt a healthy lifestyle, including smoking cessation, regular exercise, a balanced diet low in saturated fats and cholesterol, and maintaining a healthy weight. Controlling underlying risk factors such as hypertension, diabetes, and hyperlipidemia is also essential in preventing the progression of carotid artery disease and reducing the risk of stroke.
In addition to lifestyle modifications, pharmacological interventions play a crucial role in the management of carotid artery disease. Medications such as antiplatelet agents (e.g., aspirin, clopidogrel), statins, antihypertensive drugs, and anticoagulants may be prescribed to reduce the risk of blood clots, lower cholesterol levels, control blood pressure, and prevent further plaque buildup in the arteries. These medications are often used in combination with lifestyle modifications to optimize cardiovascular health and reduce the risk of stroke.
For patients with severe carotid artery stenosis or those at high risk of stroke, invasive procedures such as carotid endarterectomy (CEA) and carotid artery stenting (CAS) may be recommended. Carotid endarterectomy involves surgically removing the plaque from the inner lining of the carotid artery to restore blood flow to the brain. This procedure is typically performed under general anesthesia and requires a short hospital stay. Carotid artery stenting, on the other hand, involves inserting a stent (a small mesh tube) into the narrowed artery to hold it open and improve blood flow. This minimally invasive procedure is performed using a catheter-based approach and is often preferred for patients who are not candidates for surgery or who have high-risk anatomical features.
The carotid artery disease treatment market is influenced by various factors, including demographic trends, advancements in medical technology, healthcare policies, and reimbursement landscape. With an aging population and a growing prevalence of cardiovascular risk factors such as hypertension, diabetes, and obesity, the incidence of carotid artery disease is expected to rise globally. This trend underscores the importance of early detection, comprehensive risk assessment, and timely intervention to prevent stroke and improve patient outcomes.
Technological advancements are driving innovation in the diagnosis and treatment of carotid artery disease, with emerging trends such as high-resolution imaging, artificial intelligence (AI), and minimally invasive techniques showing promise in enhancing patient care. High-resolution imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA) enable healthcare providers to visualize the extent of carotid artery stenosis and assess the risk of stroke with greater precision. AI algorithms are being developed to analyze medical imaging data and assist clinicians in identifying high-risk plaque features, guiding treatment decisions, and predicting patient outcomes.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|
Carotid Artery Disease Market Highlights:
Carotid Artery Disease Market Overview
The carotid artery disease market is projected to grow at a substantial rate. it is projected that the market will record a CAGR of 4.52%. also, according to MRFR analysis, the market value will increase up to USD 15,341.09 million during the forecast period 2021-2030. the growing demand for carotid artery disease natural treatment is pushing the market at a substantial rate. some of the factors that are driving the market growth are the growing population of the older populations, growing awareness for treatment for carotid artery disease. hence, the carotid artery stenosis market will have substantial growth.
Carotid arteries are basically the blood vessels that help in supplying oxygen-enriched blood to the brain. The vessels usually get blocked due to calcium, cholesterol, etc. Proper medication can help in clearing the blockage in the blood vessels and carotid arteries. The carotid artery disease market on the basis of region is divided into South America, North America, Europe, Asia-Pacific, and the Middle East and Africa. According to the MRFR analysis, North America will hold the dominant share in the carotid artery stenosis market. However, the Asia-Pacific region will grow at a substantial CAGR during the forecast period as well.
Furthermore, there are some restraints that can affect the market growth during the forecast period as well. The increasing costs of treatments and diagnosis for chronic diseases can slow down growth. Along with that, the slow diagnosis process and strict regulations can hamper the market growth. However, with the presence of several key players and the investments, the Carotid artery disease market will hold its position in the upcoming years.
Covid-19 Analysis Of Carotid Artery Disease Market
The prevalence of Coronavirus disease across the world had put a huge strain upon the Carotid artery disease market. The growing number of affected patients with COVID-19 has affected the treatment of patients with other diseases. Also, it has put severe pressure on the economic condition of countries across the world. Due to border lockdowns in several countries, several factories were closed and it halted the production of various components used in the carotid artery disease and stenosis treatment. However, after the waiver on lockdowns, the market is reviving slowly and gradually. Thus, the carotid artery stenosis market is projected to regain its growth in the upcoming years.
Carotid Artery Disease Treatment Market Share, by Medication, 2017 (%) 
Source: MRFR Analysis
Carotid artery disease market Dynamics
Market Drivers
The major drivers for the carotid artery disease and stenosis treatment are the growing population of the older generation and the huge prevalence of unhealthy lifestyles. Apart from that, the increasing use of OTD or “over-the-counter drugs” will also fuel the carotid artery disease market growth in the upcoming period.
Restraints
There are some restraints that can reduce the carotid artery stenosis market growth in the upcoming years. One of the major restraints for the market is the strict regulations by the government for the treatment for carotid artery disease. Along with that, low availability of resources on the ground level can hamper market growth.
Opportunities
Some opportunities are projected to boost the market growth to a new level. Due to the growing awareness among patients for new technologies that help in early detection will open new opportunities for the market. Along with that, the improvement in treatments for stroke and heart attack will further boost the carotid artery disease market growth.
Challenges
Despite various growth opportunities, the carotid artery disease market will have some challenges. the increased cost for the carotid artery disease natural treatment will be a major challenge for people to diagnose and provide the treatment. thus, it can be a major factor affecting the carotid artery stenosis market.
Cumulative Analysis
The carotid artery disease market is estimated to have robust growth. the compound annual growth rate (CAGR) of the market is expected to grow at 4.1%. the market value is estimated to increase further up to usd 15,000 million in the forthcoming years. various factors are expected to fuel the carotid artery disease alternative treatment.
Value Chain Analysis
The carotid artery disease market will have a lucrative growth with various market developments. The growing investments by key players and the increasing prevalence of diseases related to cholesterol and heart will promote the carotid artery disease market extensively.
Asia-Pacific Carotid Artery Disease IndustryShare, by Region, 2017 (%)
Source: MRFR Analysis
Market Segmentations
The segmentation of the carotid artery disease market is divided into end-user and type. on the basis of type, the carotid artery disease market is divided into surgery, medication, and diagnosis. the diagnosis segment is divided into Duplex Ultrasound, Compound Tomography, Magnetic Resonance Imaging, and others. On the basis of treatment, the carotid artery disease market is again divided into antihypertensive drugs, antiplatelet drugs, and cholesterol-lowering statins. On the basis of surgery, the market is again divided into carotid artery angioplasty, carotid artery bypass, and carotid endarterectomy. On the basis of end-user, the carotid artery disease market is divided into clinics and hospitals, pharmacies, ambulatory surgical centers.
Regional Analysis
The carotid artery disease market is divided into south america, north america, asia-pacific, europe, and the middle east and africa. north america is estimated to hold the largest share in the market in the forthcoming years. the growing rate of the older generation and cases of life-threatening diseases in countries such as the united states and canada will cause robust growth in the forthcoming years.
Apart from that, Europe and Asia-Pacific will also have a robust growth as compared to past years. The growing spends by the government of countries in these regions in the healthcare sector is the major driver for carotid artery disease and stenosis treatment. Also, the significant development in the infrastructure, treatment and new drugs will play a major role in the growth in these regions.
Competitive Landscape
Some of the major key players fuelling the growth of the Carotid artery disease market are as follows.
- Medtronic Plc
- Pfizer
- GE Healthcare
- Cardinal Health
- Eli Lily and Company
- AdvanceCor GmbH
- Teleflex, Siemens Healthcare
- Daiichi Sankyo Co. Ltd.
- Abbot Laboratories
- Bristol-Myers Squibb
- Merck & Cp. Inc.
- Silk Road Medical
- Stryker Corporation
- Hitachi
- Terumo Corporation
- Boston Scientific Corporation
- Dickinson Company
- L. Gore & Associates, Inc.
Recent Developments
- Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
- Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.
Report Overview
The overview of the carotid artery disease and stenosis treatment market is as follows.
- Market Overview
- COVID-19 Analysis
- Dynamics of the Market
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Analysis
- Recent Development
Report Score and Segmentation
-
Study Period- 2021-2028 -
Base Year-2021 -
Forecast Period- 2021-2028 -
Historical Period-2019-2020
The report score of the treatment for carotid artery disease market highlights the growth of the market in the forecast period 2021-2028. It highlights various factors such as opportunities, drivers, market value, etc., and notable key players that will push the market.
Segmentation
By Type
- Treatment
- Diagnosis
- Duplex Ultrasound
- Compound Tomography
- Magnetic Resonance Imaging
- Others
By Medications
- Antiplatelet Drugs
- Cholesterol-Lowering Statins
- Antihypertensive Drugs
By Surgical Procedures
- Carotid Artery Angioplasty
- Carotid Artery Bypass
- Carotid Endarterectomy
By End-User
- Clinics and Hospitals
- Pharmacies
- Ambulatory Surgical Centres
By Region
- North America
- Latin America
- Asia-Pacific
- Europe
- The Middle east Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
